LSTA logo

Lisata Therapeutics (LSTA) Total Liabilities

Annual Total Liabilities

$6.80 M
+$90.00 K+1.34%

December 31, 2023


Summary


Performance

LSTA Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAbalance sheetmetrics:

Quarterly Total Liabilities

$4.76 M
+$187.00 K+4.09%

September 30, 2024


Summary


Performance

LSTA Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

LSTA Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.3%-30.0%
3 y3 years+80.8%-30.0%
5 y5 years-4.6%-30.0%

LSTA Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+35.8%-30.0%+47.8%
5 y5-yearat high+80.8%-30.0%+47.8%
alltimeall time-91.0%+1393.5%-94.5%+1512.4%

Lisata Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$4.76 M(+4.1%)
Jun 2024
-
$4.58 M(-16.8%)
Mar 2024
-
$5.50 M(-19.2%)
Dec 2023
$6.80 M(+1.3%)
$6.80 M(+26.3%)
Sep 2023
-
$5.38 M(+15.8%)
Jun 2023
-
$4.65 M(-17.3%)
Mar 2023
-
$5.62 M(-16.2%)
Dec 2022
$6.71 M(+34.0%)
$6.71 M(-0.7%)
Sep 2022
-
$6.76 M(+80.7%)
Jun 2022
-
$3.74 M(+16.1%)
Mar 2022
-
$3.22 M(-35.7%)
Dec 2021
$5.01 M(+33.2%)
-
Dec 2021
-
$5.01 M(+21.4%)
Sep 2021
-
$4.13 M(+4.8%)
Jun 2021
-
$3.94 M(-14.3%)
Mar 2021
-
$4.59 M(+22.2%)
Dec 2020
$3.76 M(-43.0%)
$3.76 M(-17.0%)
Sep 2020
-
$4.53 M(+15.5%)
Jun 2020
-
$3.92 M(-23.9%)
Mar 2020
-
$5.16 M(-21.9%)
Dec 2019
$6.60 M(-7.4%)
$6.60 M(-1.3%)
Sep 2019
-
$6.69 M(-0.6%)
Jun 2019
-
$6.73 M(-1.5%)
Mar 2019
-
$6.83 M(-4.2%)
Dec 2018
$7.13 M(-46.0%)
$7.13 M(+1.2%)
Sep 2018
-
$7.04 M(-18.3%)
Jun 2018
-
$8.63 M(-24.3%)
Mar 2018
-
$11.40 M(-13.5%)
Dec 2017
$13.19 M(-73.3%)
$13.19 M(-9.5%)
Sep 2017
-
$14.57 M(-20.0%)
Jun 2017
-
$18.21 M(-63.9%)
Mar 2017
-
$50.50 M(+2.1%)
Dec 2016
$49.45 M(+45.8%)
$49.45 M(+4.6%)
Sep 2016
-
$47.29 M(-7.4%)
Jun 2016
-
$51.08 M(+2.1%)
Mar 2016
-
$50.00 M(+47.4%)
Dec 2015
$33.92 M(-50.3%)
$33.92 M(-47.6%)
Sep 2015
-
$64.71 M(+3.2%)
Jun 2015
-
$62.67 M(-9.0%)
Mar 2015
-
$68.85 M(+0.9%)
Dec 2014
$68.20 M(+145.4%)
$68.20 M(-1.6%)
Sep 2014
-
$69.28 M(+23.5%)
Jun 2014
-
$56.10 M(+105.3%)
Mar 2014
-
$27.33 M(-1.7%)
Dec 2013
$27.79 M(+28.7%)
$27.79 M(+22.7%)
Sep 2013
-
$22.65 M(+9.9%)
Jun 2013
-
$20.62 M(-1.3%)
Mar 2013
-
$20.89 M(-3.2%)
Dec 2012
$21.59 M(-71.3%)
$21.59 M(-71.3%)
Sep 2012
-
$75.10 M(-12.8%)
Jun 2012
-
$86.17 M(+0.8%)
Mar 2012
-
$85.51 M(+13.7%)
DateAnnualQuarterly
Dec 2011
$75.20 M(+33.0%)
$75.20 M(+11.0%)
Sep 2011
-
$67.77 M(-15.6%)
Jun 2011
-
$80.26 M(+0.9%)
Mar 2011
-
$79.54 M(+40.7%)
Dec 2010
$56.54 M(+6.2%)
$56.54 M(+70.0%)
Sep 2010
-
$33.26 M(-14.8%)
Jun 2010
-
$39.06 M(-31.2%)
Mar 2010
-
$56.74 M(+6.6%)
Dec 2009
$53.24 M(+5439.9%)
$53.24 M(+411.1%)
Sep 2009
-
$10.42 M(+20.7%)
Jun 2009
-
$8.63 M(+230.0%)
Mar 2009
-
$2.62 M(+172.1%)
Dec 2008
$961.10 K(+109.4%)
$961.10 K(+109.8%)
Sep 2008
-
$458.10 K(+55.1%)
Jun 2008
-
$295.40 K(-26.4%)
Mar 2008
-
$401.40 K(-12.5%)
Dec 2007
$459.00 K(-49.2%)
$459.00 K(+21.1%)
Sep 2007
-
$379.00 K(-53.3%)
Jun 2007
-
$812.20 K(+46.9%)
Mar 2007
-
$553.00 K(-38.8%)
Dec 2006
$902.90 K(-63.3%)
$902.90 K(+38.2%)
Sep 2006
-
$653.40 K(-76.8%)
Jun 2006
-
$2.81 M(+47.1%)
Mar 2006
-
$1.91 M(-22.3%)
Dec 2005
$2.46 M(+21.1%)
$2.46 M(-4.9%)
Sep 2005
-
$2.59 M(+10.1%)
Jun 2005
-
$2.35 M(+9.8%)
Mar 2005
-
$2.14 M(+5.4%)
Dec 2004
$2.03 M(+11.9%)
$2.03 M(-7.4%)
Sep 2004
-
$2.19 M(+10.9%)
Jun 2004
-
$1.98 M(+0.8%)
Mar 2004
-
$1.96 M(+8.2%)
Dec 2003
$1.81 M(-9.6%)
$1.81 M(-0.6%)
Sep 2003
-
$1.82 M(-23.1%)
Jun 2003
-
$2.37 M(+11.1%)
Mar 2003
-
$2.14 M(+6.5%)
Dec 2002
$2.01 M(+37.2%)
$2.01 M(+3.5%)
Sep 2002
-
$1.94 M(+15.7%)
Jun 2002
-
$1.68 M(+10.0%)
Mar 2002
-
$1.52 M(+4.3%)
Dec 2001
$1.46 M(+11.9%)
$1.46 M(+1.5%)
Sep 2001
-
$1.44 M(+3.2%)
Jun 2001
-
$1.40 M(+5.2%)
Mar 2001
-
$1.33 M(+1.5%)
Dec 2000
$1.31 M(+4.7%)
$1.31 M(+0.4%)
Sep 2000
-
$1.30 M(+13.1%)
Jun 2000
-
$1.15 M(+17.5%)
Mar 2000
-
$980.00 K
Dec 1999
$1.25 M(+2.9%)
-
Dec 1998
$1.21 M(+5.2%)
-
Mar 1998
$1.15 M(+73.1%)
-
Mar 1997
$666.60 K(+46.4%)
-
Mar 1996
$455.30 K
-

FAQ

  • What is Lisata Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Lisata Therapeutics?
  • What is Lisata Therapeutics annual total liabilities year-on-year change?
  • What is Lisata Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly total liabilities year-on-year change?

What is Lisata Therapeutics annual total liabilities?

The current annual total liabilities of LSTA is $6.80 M

What is the all time high annual total liabilities for Lisata Therapeutics?

Lisata Therapeutics all-time high annual total liabilities is $75.20 M

What is Lisata Therapeutics annual total liabilities year-on-year change?

Over the past year, LSTA annual total liabilities has changed by +$90.00 K (+1.34%)

What is Lisata Therapeutics quarterly total liabilities?

The current quarterly total liabilities of LSTA is $4.76 M

What is the all time high quarterly total liabilities for Lisata Therapeutics?

Lisata Therapeutics all-time high quarterly total liabilities is $86.17 M

What is Lisata Therapeutics quarterly total liabilities year-on-year change?

Over the past year, LSTA quarterly total liabilities has changed by -$2.04 M (-29.96%)